Technical Analysis for ANIP - ANI Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 54.67 1.18% 0.64
ANIP closed up 1.18 percent on Friday, January 18, 2019, on 64 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ANIP trend table...

Date Alert Name Type % Chg
Jan 18 180 Bullish Setup Bullish Swing Setup 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 17 Shooting Star Candlestick Bearish 1.18%
Jan 17 Lizard Bearish Bearish Day Trade Setup 1.18%
Jan 17 Wide Bands Range Expansion 1.18%
Jan 17 Overbought Stochastic Strength 1.18%
Jan 16 Pocket Pivot Bullish Swing Setup 1.05%
Jan 16 Wide Bands Range Expansion 1.05%
Jan 16 Overbought Stochastic Strength 1.05%

Older signals for ANIP ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
ANI Pharmaceuticals, Inc. develops, manufactures, and markets prescription and over-the-counter pharmaceuticals. It offers liquid, powder, oral solid dose, and cough/cold products; and antacids, laxatives, and other stomach remedies. The company also provides hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture, and metoclopramide tablets. In addition, ANI Pharmaceuticals offers contract manufacturing services for other pharmaceutical companies. It offers its products through wholesalers, smaller regional distributors and chains, and pharmacy and retail outlets in the United States. ANI Pharmaceuticals, Inc. was formerly known as ASHCO. The company was founded in 2001 and is based in Baudette, Minnesota. It has manufacturing facilities in Gulfport, Mississippi; and Baudette, Minnesota. ANI Pharmaceuticals, Inc. is a former subsidiary of Bactolac Pharmaceutical Inc.
Is ANIP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 72.85
52 Week Low 36.92
Average Volume 77,169
200-Day Moving Average 58.2597
50-Day Moving Average 51.4124
20-Day Moving Average 48.6105
10-Day Moving Average 52.928
Average True Range 2.1198
ADX 22.85
+DI 25.8706
-DI 18.9712
Chandelier Exit (Long, 3 ATRs ) 48.7006
Chandelier Exit (Short, 3 ATRs ) 43.2794
Upper Bollinger Band 57.9419
Lower Bollinger Band 39.2791
Percent B (%b) 0.82
BandWidth 38.392528
MACD Line 1.1402
MACD Signal Line 0.2334
MACD Histogram 0.9068
Fundamentals Value
Market Cap 636.25 Million
Num Shares 11.6 Million
EPS 0.46
Price-to-Earnings (P/E) Ratio 118.85
Price-to-Sales 4.26
Price-to-Book 3.82
PEG Ratio 1.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 57.24
Resistance 3 (R3) 57.02 55.95 56.81
Resistance 2 (R2) 55.95 55.30 56.06 56.66
Resistance 1 (R1) 55.31 54.89 55.63 55.53 56.52
Pivot Point 54.24 54.24 54.40 54.35 54.24
Support 1 (S1) 53.60 53.59 53.92 53.82 52.82
Support 2 (S2) 52.53 53.18 52.64 52.68
Support 3 (S3) 51.89 52.53 52.53
Support 4 (S4) 52.11